神经功能损害患儿胃造瘘术的结局:一项系统评价。
完整摘要 · 中文译文
引言:胃造瘘喂养广泛用于神经功能障碍且经口摄入不足的儿童,但尚未对家庭重点关注的多项结局证据进行综合。既往系统评价仅限于脑性瘫痪,且未发现对照研究。本研究旨在评估胃造瘘与继续经口/鼻胃管喂养在营养、呼吸、神经发育及照护者报告结局方面的差异,并量化并发症。 方法:按照PRISMA 2020指南开展了一项PROSPERO注册的系统评价(CRD420261483110)。检索5个数据库至2026年7月15日,纳入0-18岁接受胃造瘘的神经功能障碍儿童。实施双人筛选、数据提取及偏倚风险评估(RoB 2、ROBINS-I、JBI、CASP)。异质性阻碍了荟萃分析;叙述性综合优先考虑研究设计和方法学质量,而非按效应方向计票。 结果:从5,503条记录中,120项研究(约117个队列,30个国家)符合标准。证据以观察性研究为主,多数比较性研究存在严重偏倚风险。56项研究中多数营养状况改善,尽管较早置管与更显著的追赶生长相关,但不能确立因果关系。在56项呼吸系统研究中,较小队列报告感染较少,但最大的倾向匹配和人群关联数据集显示肺炎住院无减少,在某些分析中反而增加。轻微并发症常见 (20%-95%)。主要并发症在不合并抗反流手术时集中在0%-3%,但在增加胃底折叠术或空肠延伸后上升了数倍。反流结局(59项研究)取决于术前状态;根据有限的生理学数据推测,胃造瘘可能在既往无反流的儿童中增加新发反流风险,尽管<10%需要后续抗反流手术。全因死亡率(67项研究)较高但为疾病相关;手术归因死亡罕见,在最脆弱群体之外,30天死亡率为0%-3%。生活质量数据(21项研究)显示,14/17项研究中照护者结局良好,但儿童的生活质量仅被正确测量过一次,且无变化。仅11项研究涉及神经发育;唯一使用标准化工具的研究发现认知恢复与喂养途径无关。 讨论:胃造瘘始终与基于体重的营养状况改善相关,并且在不合并抗反流手术时,严重手术伤害发生率低。它并不能消除误吸风险,且据推测会在既往无反流的儿童中增加新发反流风险。经 validated measurement,照护者生活质量改善;然而,现有证据不足以确定胃造瘘对儿童神经发育是有利、不利还是中性影响。 系统综述注册:PROSPERO:https://www.crd.york.ac.uk/PROSPERO/view/CRD420261483110。
完整摘要 · 英文原文
INTRODUCTION: Gastrostomy feeding is widely used for children with neurological impairment and inadequate oral intake, but evidence across family-important outcomes has not been synthesised. Previous systematic reviews were restricted to cerebral palsy and found no controlled studies. The objective of this study is to assess gastrostomy vs. continued oral/nasogastric feeding on nutritional, respiratory, neurodevelopmental, and caregiver-reported outcomes, and to quantify complications. METHODS: A PROSPERO-registered systematic review (CRD420261483110) was conducted following PRISMA 2020 guidelines. Five databases were searched to 15 July 2026 for children aged 0-18 with neurological impairment undergoing gastrostomy. Duplicate screening, data extraction, and risk-of-bias appraisal (RoB 2, ROBINS-I, JBI, CASP) were performed. Heterogeneity precluded meta-analysis; narrative synthesis prioritized study design and methodological quality over direction-of-effect vote counting. RESULTS: From 5,503 records, 120 studies (≈117 cohorts, 30 countries) met the criteria. The evidence was predominantly observational, and most comparative studies carried a serious risk of bias. Nutritional status improved in the majority of 56 studies, though earlier placement's association with more robust catch-up growth does not establish causality. Among 56 respiratory studies, smaller cohorts reported fewer infections, but the largest propensity-matched and population-linked datasets showed no reduction, and in some analyses an increase, in pneumonia hospitalisations. Minor complications were common (20%-95%). Major complications clustered at 0%-3% without concurrent antireflux surgery, but rose several-fold when fundoplication or jejunal extensions were added. Reflux outcomes (59 studies) depended on preoperative status; it is hypothesized from limited physiological data that gastrostomy may increase de novo reflux risk in previously reflux-free children, though <10% required subsequent antireflux surgery. All-cause mortality (67 studies) was high but disease-related; procedure-attributable death was rare, and 30-day mortality was 0%-3% outside the most fragile groups. Quality-of-life data (21 studies) showed favourable caregiver outcomes in 14/17 studies, but the child's quality of life has been measured properly only once and was unchanged. Only 11 studies addressed neurodevelopment; the single study using a standardised instrument found cognitive recovery unrelated to the feeding route. DISCUSSION: Gastrostomy is consistently associated with improved weight-based nutritional status and carries low serious surgical harm when performed without concurrent antireflux surgery. It does not eliminate aspiration risk and is hypothesized to increase de novo reflux risk in previously reflux-free children. Caregiver quality of life improves on validated measurement; however, the available evidence is insufficient to determine whether gastrostomy has a favourable, unfavourable, or neutral effect on a child's neurodevelopment. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261483110.